Biophysical characterization and membrane interaction of the most membranotropic region of the HIV-1 gp41 endodomain

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 5, 2008, Pages 1298-1307

  Moreno, Miguel R ^a   Pérez Berná, Ana J ^a   Guillén, Jaime ^a   Villalaín, José ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Gp41 endodomain; HIV; LLP3; Peptide lipid interaction

Indexed keywords

GLYCOPROTEIN GP 41; LENTIVIRUS LYTIC PEPTIDE; LIPOSOME; PEPTIDE;

ARTICLE; CALORIMETRY; CYTOPLASM; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MEMBRANE DAMAGE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; BIOPHYSICS; CALORIMETRY, DIFFERENTIAL SCANNING; HIV ENVELOPE PROTEIN GP41; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; SPECTRUM ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 43049171646     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.12.023     Document Type: Article

References (74)

1. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Ann. Rev. Biochem. 70 (2001) 777-810
2. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., Puri A., Durell S., and Blumenthal R. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614 (2003) 36-50
3. Markovic I., and Clouse K.A. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention. Curr. HIV Res. 2 (2004) 223-234
4. Earp L.J., Delos S.E., Park H.E., and White J.M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285 (2005) 25-66
5. Dong X.N., Xiao Y., Dierich M.P., and Chen Y.H. N- and C-domains of HIV-1 gp41: mutation, structure and functions. Immunol. Lett. 75 (2001) 215-220
6. Bosch M.L., Earl P.L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., and Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science 244 (1989) 694-697
7. Gallaher W.R., Ball J.M., Garry R.F., Griffin M.C., and Montelaro R.C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retrovir. 5 (1989) 431-440
8. Pascual R., Moreno M.R., and Villalain J. A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism. J. Virol. 79 (2005) 5142-5152
9. Pascual R., Contreras M., Fedorov A., Prieto M., and Villalain J. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Biochemistry 44 (2005) 14275-14288
10. Suarez T., Nir S., Goni F.M., Saez-Cirion A., and Nieva J.L. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett. 477 (2000) 145-149
11. Moreno M.R., Giudici M., and Villalain J. The membranotropic regions of the endo and ecto domains of HIV gp41 envelope glycoprotein. Biochim. Biophys. Acta 1758 (2006) 111-123
12. Contreras L.M., Aranda F.J., Gavilanes F., Gonzalez-Ros J.M., and Villalain J. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism. Biochemistry 40 (2001) 3196-3207
13. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39 (2000) 1826-1833
14. Sackett K., and Shai Y. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion. Biochemistry 41 (2002) 4678-4685
15. Dimitrov A.S., Rawat S.S., Jiang S., and Blumenthal R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry 42 (2003) 14150-14158
16. Hunter E., and Swanstrom R. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157 (1990) 187-253
17. Jiang J., and Aiken C. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J. Virol. 81 (2007) 9999-10008
18. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., and Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 78 (2004) 3429-3435
19. Lee S.J., Hu W., Fisher A.G., Looney D.J., Kao V.F., Mitsuya H., Ratner L., and Wong-Staal F. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res. Hum. Retrovir. 5 (1989) 441-449
20. Dubay J.W., Roberts S.J., Hahn B.H., and Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66 (1992) 6616-6625
21. Gabuzda D.H., Lever A., Terwilliger E., and Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66 (1992) 3306-3315
22. Piller S.C., Dubay J.W., Derdeyn C.A., and Hunter E. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity. J. Virol. 74 (2000) 11717-11723
23. Akari H., Fukumori T., and Adachi A. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J. Virol. 74 (2000) 4891-4893
24. Murakami T., and Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74 (2000) 3548-3554
25. Vzorov A.N., Weidmann A., Kozyr N.L., Khaoustov V., Yoffe B., and Compans R.W. Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection. Retrovirology 4 (2007) 94
26. Wyss S., Dimitrov A.S., Baribaud F., Edwards T.G., Blumenthal R., and Hoxie J.A. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol. 79 (2005) 12231-12241
27. Miller M.A., Cloyd M.W., Liebmann J., Rinaldo Jr. C.R., Islam K.R., Wang S.Z., Mietzner T.A., and Montelaro R.C. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196 (1993) 89-100
28. Gawrisch K., Han K.H., Yang J.S., Bergelson L.D., and Ferretti J.A. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry 32 (1993) 3112-3118
29. Srinivas S.K., Srinivas R.V., Anantharamaiah G.M., Segrest J.P., and Compans R.W. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J. Biol. Chem. 267 (1992) 7121-7127
30. Kliger Y., and Shai Y. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Biochemistry 36 (1997) 5157-5169
31. Fujii G., Horvath S., Woodward S., Eiserling F., and Eisenberg D. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41. Protein Sci. 1 (1992) 1454-1464
32. Miller M.A., Mietzner T.A., Cloyd M.W., Robey W.G., and Montelaro R.C. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res. Hum. Retrovir. 9 (1993) 1057-1066
33. Srinivas S.K., Srinivas R.V., Anantharamaiah G.M., Compans R.W., and Segrest J.P. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J. Biol. Chem. 268 (1993) 22895-22899
34. Zhang H., Wang L., Kao S., Whitehead I.P., Hart M.J., Liu B., Duus K., Burridge K., Der C.J., and Su L. Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. Curr. Biol. 9 (1999) 1271-1274
35. Surewicz W.K., Mantsch H.H., and Chapman D. Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochemistry 32 (1993) 389-394
36. Zhang Y.P., Lewis R.N., Hodges R.S., and McElhaney R.N. FTIR spectroscopic studies of the conformation and amide hydrogen exchange of a peptide model of the hydrophobic transmembrane alpha-helices of membrane proteins. Biochemistry 31 (1992) 11572-11578
37. Mayer L.D., Hope M.J., and Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858 (1986) 161-168
38. Böttcher C.S.F., Van Gent C.M., and Fries C. A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta 1061 (1961) 203-204
39. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6 (1967) 1948-1954
40. Sainz, Jr. B., Rausch J.M., Gallaher W.R., Garry R.F., and Wimley W.C. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J. Virol. 79 (2005) 7195-7206
41. Eftink M.R., and Ghiron C.A. Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry 15 (1976) 672-680
42. Castanho M., and Prieto M. Filipin fluorescence quenching by spin-labeled probes: studies in aqueous solution and in a membrane model system. Biophys. J. 69 (1995) 155-168
43. Wardlaw J.R., Sawyer W.H., and Ghiggino K.P. Vertical fluctuations of phospholipid acyl chains in bilayers. FEBS Lett. 223 (1987) 20-24
44. Santos N.C., Prieto M., and Castanho M.A. Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. Biochemistry 37 (1998) 8674-8682
45. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
46. Bernabeu A., Guillen J., Perez-Berna A.J., Moreno M.R., and Villalain J. Structure of the C-terminal domain of the pro-apoptotic protein Hrk and its interaction with model membranes. Biochim. Biophys. Acta 1768 (2007) 1659-1670
47. Giudici M., Pascual R., de la Canal L., Pfuller K., Pfuller U., and Villalain J. Interaction of viscotoxins A3 and B with membrane model systems: implications to their mechanism of action. Biophys. J. 85 (2003) 971-981
48. Bohm G., Muhr R., and Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. 5 (1992) 191-195
49. Moreno M.R., Guillen J., Perez-Berna A.J., Amoros D., Gomez A.I., Bernabeu A., and Villalain J. Characterization of the interaction of two peptides from the N-terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Biochemistry 46 (2007) 10572-10584
50. Garcia-Saez A.J., Coraiola M., Serra M.D., Mingarro I., Muller P., and Salgado J. Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores. FEBS J. 273 (2006) 971-981
51. Huang H.W. Action of antimicrobial peptides: two-state model. Biochemistry 39 (2000) 8347-8352
52. Steiner H., Andreu D., and Merrifield R.B. Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim. Biophys. Acta 939 (1988) 260-266
53. Janowska-Wieczorek A., Matsuzaki A., and L A.M. The hematopoietic microenvironment: matrix metalloproteinases in the hematopoietic microenvironment. Hematol 4 (2000) 515-527
54. Tas M., Drexhage H.A., and Goudsmit J. A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41. Clin. Exp. Immunol. 71 (1988) 13-18
55. Benachir T., and Lafleur M. Study of vesicle leakage induced by melittin. Biochim. Biophys. Acta 1235 (1995) 452-460
56. Colman P.M., and Lawrence M.C. The structural biology of type I viral membrane fusion. Nat. Rev., Mol. Cell Biol. 4 (2003) 309-319
57. LeDuc D.L., and Shin Y.K. Insights into a structure-based mechanism of viral membrane fusion. Biosci. Rep. 20 (2000) 557-570
58. Weissenhorn W., Dessen A., Calder L.J., Harrison S.C., Skehel J.J., and Wiley D.C. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16 (1999) 3-9
59. Blumenthal R., Clague M.J., Durell S.R., and Epand R.M. Membrane fusion. Chem. Rev. 103 (2003) 53-69
60. Brasseur R., Cornet B., Burny A., Vandenbranden M., and Ruysschaert J.M. Mode of insertion into a lipid membrane of the N-terminal HIV gp41 peptide segment. AIDS Res. Hum. Retrovir. 4 (1988) 83-90
61. Rabenstein M., and Shin Y.K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34 (1995) 13390-13397
62. Saez-Cirion A., Arrondo J.L., Gomara M.J., Lorizate M., Iloro I., Melikyan G., and Nieva J.L. Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation. Biophys. J. 85 (2003) 3769-3780
63. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3 (1996) 842-848
64. White S.H., and Wimley W.C. Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 28 (1999) 319-365
65. Engelman D.M., Steitz T.A., and Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Biophys. Chem. 15 (1986) 321-353
66. Mornon J.P., Bissery V., Gaboriaud C., Thomas A., Ojasoo T., and Raynaud J.P. Hydrophobic cluster analysis (HCA) of the hormone-binding domain of receptor proteins. J. Steroid Biochem. 34 (1989) 355-361
67. Gaboriaud C., Bissery V., Benchetrit T., and Mornon J.P. Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences. FEBS Lett. 224 (1987) 149-155
68. Korazim O., Sackett K., and Shai Y. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended. J. Mol. Biol. 364 (2006) 1103-1117
69. Chen S.S., Lee S.F., and Wang C.T. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. J. Virol. 75 (2001) 9925-9938
70. Lee S.F., Wang C.T., Liang J.Y., Hong S.L., Huang C.C., and Chen S.S. Multimerization potential of the cytoplasmic domain of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J. Biol. Chem. 275 (2000) 15809-15819
71. McElhaney R.N. The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chem. Phys. Lipids 30 (1982) 229-259
72. Papahadjopoulos D., Moscarello M., Eylar E.H., and Isac T. Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim. Biophys. Acta 401 (1975) 317-335
73. Hollier M.J., and Dimmock N.J. The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function. Virology 337 (2005) 284-296
74. Moreno M.R., Pascual R., and Villalain J. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan. Biochim. Biophys. Acta 1661 (2004) 97-105